4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Mimọ ≥99.5% (GC) Ile-iṣẹ Tita Gbona
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Orukọ Kemikali | 4,6-Dichloro-2-Methylpyrimidine |
Awọn itumọ ọrọ sisọ | 2-Methyl-4,6-Dichloropyrimidine;2,4-Dichloro-6-Methylpyrimidine |
Nọmba CAS | 1780-26-3 |
NỌMBA CAT | RF-PI687 |
Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu |
Fọọmu Molecular | C5H4Cl2N2 |
Òṣuwọn Molikula | 163.00 |
Ojuami Iyo | 41.5 ~ 45.5 ℃ (tan.) |
Solubility (Solubility in) | kẹmika kẹmika |
Brand | Ruifu Kemikali |
Nkan | Awọn pato |
Ifarahan | Funfun tabi Pa-White Crystalline Powder |
Mimọ / Analysis Ọna | ≥99.5% (GC) |
Pipadanu lori Gbigbe | ≤0.50% |
Aloku lori Iginisonu | ≤0.20% |
Nikan Aimọ | ≤0.50% |
Lapapọ Awọn Aimọ | ≤0.50% |
Igbeyewo Standard | Standard Enterprise |
Lilo | Elegbogi Intermediate;Dasatinib/Moxonidine Intermediate |
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) Ilana Ilana
Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) ni a lo ninu iṣelọpọ ti awọn agbedemeji elegbogi ati awọn API.Awọn ọja Igbaradi: Moxonidine (CAS: 75438-57-2);Dasatinib (CAS: 302962-49-8);Dasatinib Monohydrate (CAS: 863127-77-9);4-Chloro-2,6-Dimethylpyrimidine (CAS: 4472-45-1);4-Amino-6-Chloro-2-Methylpyrimidine (CAS: 1749-68-4).Moxonidine jẹ iru tuntun ti oogun apakokoro, ti a lo nigbagbogbo ni itọju haipatensonu pataki.Ti a fiwera si awọn antihypertensive ti aarin ti ogbo agbalagba, Moxonidine sopọ pẹlu isunmọ ti o tobi pupọ si imidazoline I1-receptor ju si α2-receptor.Dasatinib jẹ inhibitor oncogenic kinase ti o ni agbara ẹnu, eyiti o le ṣe idiwọ ifihan agbara isare isọdọtun sẹẹli alakan, ni Oṣu Karun ọdun 2009, Ile-iṣẹ Ounje ati Oògùn AMẸRIKA (FDA) fọwọsi ni deede fun tita dasatinib, O ti lo ni ile-iwosan fun itọju ti ọpọlọpọ onibaje onibaje. myeloid lukimia (CML), pẹlu itọju ti onibaje myeloid lukimia ti o jẹ sooro tabi ailagbara si awọn eto itọju pẹlu imatinib mesylate., Philadelphia chromosome-positive lymphoblastic leukemia (Ph + ALL) ati itọju awọn alaisan ti o ni awọn èèmọ to lagbara.